首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组人粒细胞集落刺激因子干预后自体骨髓移植对骨折愈合的影响
引用本文:张爱国,蔡建平,杨掌权.重组人粒细胞集落刺激因子干预后自体骨髓移植对骨折愈合的影响[J].中国神经再生研究,2010,14(37):6852-6856.
作者姓名:张爱国  蔡建平  杨掌权
作者单位:南京中医药大学无锡附属医院(无锡市中医医院)骨伤科,江苏省无锡市 214001,南京中医药大学无锡附属医院(无锡市中医医院)骨伤科,江苏省无锡市 214001;南京中医药大学,江苏省南京市210029,南京中医药大学无锡附属医院(无锡市中医医院)骨伤科,江苏省无锡市 214001
基金项目:江苏省中医药局2005~2006年度科研项目(H05100)
摘    要:背景:自体骨髓经皮移植促进骨折愈合已经成为临床一种治疗手段,其中骨髓间充质干细胞在局部微环境下所起到的作用已经得到共识。但是如何提高其在移植骨髓中的含量仍是目前面临的难题。已经有研究报道重组人粒细胞集落刺激因子(recombinant human granulocyte colony-stimulating factor,rhG-CSF)可动员外周骨髓间充质干细胞快速增殖。 目的:探讨rhG-CSF干预的自体骨髓移植对兔桡骨骨折愈合的促进作用。 方法:制备桡骨中段3 mm宽骨折模型白兔56只,随机分为4组,每组14只。术后1 h,rhG-CSF组,自体骨髓组与PBS对照组均在白兔背部皮下注射rhG-CSF,1次/d,连续5 d。模型组皮下注射相应体积的生理盐水。术后5 d,自体骨髓组抽取自体骨髓经皮回植骨折部位,PBS对照组在骨折处注射相应体积的生理盐水。术后14,28 d取材进行影像学、组织学、组织形态计量学检测与分析。 结果与结论:rhG-CSF,自体骨髓,PBS对照组新生血管、骨小梁形成、4种骨痂记分、外骨痂厚度均优于模型组,尤以自体骨髓组效果最显著(P < 0.01或P < 0.05)。说明rhG-CSF干预能够促进骨折愈合,结合自体骨髓移植促进骨折愈合的效果更佳。

关 键 词:重组人粒细胞集落刺激因子  骨髓  自体  移植  骨折愈合
收稿时间:2/4/2010 12:00:00 AM
修稿时间:2/4/2010 12:00:00 AM

Effect of autologous bone marrow transplantation on fracture healing following recombinant human granulocyte colony-stimulating factor intervention
Zhang Ai-guo,Cai Jian-ping and Yang Zhang-quan.Effect of autologous bone marrow transplantation on fracture healing following recombinant human granulocyte colony-stimulating factor intervention[J].Neural Regeneration Research,2010,14(37):6852-6856.
Authors:Zhang Ai-guo  Cai Jian-ping and Yang Zhang-quan
Institution:Department of Orthopaedics, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine (Wuxi Hospital of Chinese Medicine), Wuxi 214001, Jiangsu Province, China,Department of Orthopaedics, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine (Wuxi Hospital of Chinese Medicine), Wuxi 214001, Jiangsu Province, China; Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China,Department of Orthopaedics, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine (Wuxi Hospital of Chinese Medicine), Wuxi 214001, Jiangsu Province, China
Abstract:BACKGROUND: It becomes a clinical method using autologous bone marrow transplantation to promote bone union, in which the role of bone mesenchymal stem cells in the local environment had been given consensus. However, how to increase content of mesenchymal stem cells in bone marrow transplantation is still in research. It have been reported that recombinant human granulocyte colony-stimulating factor (rhG-CSF) can mobilize peripheral mesenchymal stem cells proliferate rapidly. OBJECTIVE: To investigate the effects of autologous bone marrow transplantation mobilized by rhG-CSF on promoting fracture healing of rabbits with radius fracture. METHODS: Fifty-six rabbits replicated to fracture models and were randomly divided into 4 groups, with 14 animals in each group. One hour after operation, subcutaneous injection of rhG-CSF were given to rats in the rhG-CSF, autologous bone marrow and control groups, once per day, for 5 successive days. The appropriate volume of saline solution was injected into rats in the model group. At 5 days after operation, autologous bone marrow were extracted and transplanted into autologous fracture site in the autologous bone marrow group, the appropriate volume of saline solution was injected in the control group. The specimens were taken from the rabbits at postoperative 14 and 28 days and detected by imageology, histology and morphometry. RESULTS AND CONCLUSION: The new vessels, bone trabecula formation, scores of 4 callus and thickness of the external callus in the rhG-CSF, autologous bone marrow and control groups were superior to that of the model group, in particular in the autologous bone marrow group (P < 0.01 or P < 0.05). RhG-CSF intervention can promote fracture healing, and the effect would be better if combined with autologous bone marrow transplantation.
Keywords:Recombinant Human Granulocyte Colony-stimulating Factor  Bone Marrow  transplantation  fracture healing
点击此处可从《中国神经再生研究》浏览原始摘要信息
点击此处可从《中国神经再生研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号